ALLR...$3.05...Off my $1.44 Alert...🥳NEWS...
Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early discontinuation of its Phase 2 clinical trial of stenoparib, a novel PARP inhibitor, for the treatment of advanced recurrent ovarian cancer. The patients enrolled in the trial had been pre-screened by Allarity’s unique Drug Response predictor (DRP®) companion diagnostic (CDx) in order to treat only patients with the highest likelihood of deriving clinical benefit.
The trial, evaluating stenoparib given twice daily, has shown clear clinical benefit, including tumor shrinkage and long-term disease stability, in heavily pre-treated ovarian cancer patients who otherwise have limited life expectancy. These results have provided sufficient clinical proof of concept for stenoparib as monotherapy, prompting Allarity to halt further enrollment in this trial to enable and accelerate the development of a follow-on trial with FDA regulatory intent.
georgie18
Member Level
Re: georgie18 post# 640832
Friday, April 26, 2024 10:15:32 AM
Post#
641403
of 641980
ALLR...$1.55...🥳...Bullish Reversal Confirmation Candle setting up here...Watch for Bullish Psar flip and $1.72 Breakout...imo...we shall see...
georgie18
Member Level
Re: None
Tuesday, April 23, 2024 8:32:37 AM
Post#
640832
of 641402
ALLR...$1.44...Reversal Candle on yesterdays candle...Looking for confirmation Candle today...🥳
News 
Market Data 
Discover 
